Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Bowel (colorectal) cancer, Rectal cancer
Closed
Phase 2
This trial is looking at a drug called dalotuzumab alongside irinotecan for cancer of the back passage (rectum) that has spread to other parts of the body.
Recruitment start: 18 October 2012
Recruitment end: 6 August 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Watkins
Experimental Cancer Medicine Centre (ECMC)
Merck Sharp & Dohme Ltd
NIHR Clinical Research Network: Cancer
Last reviewed: 19 August 2013
CRUK internal database number: 9860
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
